Prof. Dr. Gerold Schuler



Organisationseinheit


Lehrstuhl für Haut- und Geschlechtskrankheiten


Preise / Auszeichnungen


2010 : Mitgliedschaft Nationale Akademie der Wissenschaften Leopoldina
1998 : Mitgliedschaft Österreichische Akademie der Wissenschaften


Publikationen (Download BibTeX)

Go to first page Go to previous page 1 von 10 Go to next page Go to last page

Simon, B., Harrer, D.C., Schuler-Thurner, B., Schuler, G., & Uslu, U. (2019). Arming T cells with a gp100-specific TCR and a CSPG4-specific CAR using combined DNA-and RNA-based receptor transfer. Cancers, 11(5). https://dx.doi.org/10.3390/cancers11050696
Schneiderbanger, C.K., Schuler, G., Heinzerling, L., & Kirchberger, M.C. (2019). Characterization of tanning behavior assessed via online survey: Attitudes, habits, and preventive measures with focus on sunscreen use. Photodermatology Photoimmunology & Photomedicine, 35(4), 268-274. https://dx.doi.org/10.1111/phpp.12465
Harrer, D.C., Schuler, G., Dörrie, J., & Schaft, N. (2019). CSPG4-Specific CAR T Cells for High-Risk Childhood B Cell Precursor Leukemia. International Journal of Molecular Sciences, 20(11). https://dx.doi.org/10.3390/ijms20112764
Riethdorf, S., Hildebrandt, L., Heinzerling, L., Heitzer, E., Fischer, N., Bergmann, S.,... Pantel, K. (2019). Detection and Characterization of Circulating Tumor Cells in Patients with Merkel Cell Carcinoma. Clinical Chemistry, 65(3), 462-472. https://dx.doi.org/10.1373/clinchem.2018.297028
Simon, B., Harrer, D.C., Thirion, C., Schuler-Thurner, B., Schuler, G., & Uslu, U. (2019). Enhancing lentiviral transduction to generate melanoma-specific human T cells for cancer immunotherapy. Journal of Immunological Methods. https://dx.doi.org/10.1016/j.jim.2019.06.015
Krueckel, A., Moreira, A., Froehlich, W., Schuler, G., & Heinzerling, L. (2019). Eosinophil-cationic protein - a novel liquid prognostic biomarker in melanoma. BMC Cancer, 19. https://dx.doi.org/10.1186/s12885-019-5384-z
Lee, J.-H., Dindorf, J., Eberhardt, M., Lai, X., Ostalecki, C., Koliha, N.,... Baur, A. (2019). Innate extracellular vesicles from melanoma patients suppress beta-catenin in tumor cells by miRNA-34a. Life Science Alliance, 2(2). https://dx.doi.org/10.26508/lsa.201800205
Moreira, A., Loquai, C., Pfoefer, C., Kaehler, K.C., Knauss, S., Heppt, M.V.,... Heinzerling, L. (2019). Myositis and neuromuscular side-effects induced by immune checkpoint inhibitors. European journal of cancer, 106, 12-23. https://dx.doi.org/10.1016/j.ejca.2018.09.033
Moreira, A., Gross, S., Kirchberger, M.C., Erdmann, M., Schuler, G., & Heinzerling, L. (2019). Senescence markers: Predictive for response to checkpoint inhibitors. International Journal of Cancer, 144(5), 1147-1150. https://dx.doi.org/10.1002/ijc.31763
Simon, B., Wiesinger, M., Maerz, J., Wistuba-Hamprecht, K., Weide, B., Schuler-Thurner, B.,... Uslu, U. (2019). The transfection of natural killer T cells with a tumor-antigen specific chimeric antigen receptor (CAR) for melanoma immunotherapy. In EXPERIMENTAL DERMATOLOGY (pp. E56-E57). HOBOKEN: WILEY.

Zuletzt aktualisiert 2016-08-06 um 02:00